gallic acid has been researched along with Hypertension in 14 studies
gallate : A trihydroxybenzoate that is the conjugate base of gallic acid.
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These results suggested that gallic acid may be a potential therapeutic agent for the treatment of cardiovascular diseases with hypertension and cardiac fibrosis." | 7.85 | Gallic acid attenuates hypertension, cardiac remodeling, and fibrosis in mice with NG-nitro-L-arginine methyl ester-induced hypertension via regulation of histone deacetylase 1 or histone deacetylase 2. ( Cho, JY; Choi, SY; Jeong, MH; Jin, L; Kee, HJ; Kim, GR; Lin, MQ; Piao, ZH; Ryu, Y; Sun, S, 2017) |
| "Gallic acid (GA) has been reported to have beneficial effects on cancer, vascular calcification, and diabetes-induced myocardial dysfunction." | 5.46 | Gallic Acid Reduces Blood Pressure and Attenuates Oxidative Stress and Cardiac Hypertrophy in Spontaneously Hypertensive Rats. ( Choi, SY; Jeong, MH; Jin, L; Kee, HJ; Kim, GR; Lin, MQ; Liu, B; Piao, ZH; Ryu, Y; Seok, YM; Sun, S, 2017) |
| " The protective effects of SA are mediated by reducing oxidative stress and retaining the bioavailability of NO in the cardiovascular system." | 5.38 | Syringic acid ameliorates (L)-NAME-induced hypertension by reducing oxidative stress. ( Kumar, S; Prahalathan, P; Raja, B, 2012) |
| "These results suggested that gallic acid may be a potential therapeutic agent for the treatment of cardiovascular diseases with hypertension and cardiac fibrosis." | 3.85 | Gallic acid attenuates hypertension, cardiac remodeling, and fibrosis in mice with NG-nitro-L-arginine methyl ester-induced hypertension via regulation of histone deacetylase 1 or histone deacetylase 2. ( Cho, JY; Choi, SY; Jeong, MH; Jin, L; Kee, HJ; Kim, GR; Lin, MQ; Piao, ZH; Ryu, Y; Sun, S, 2017) |
| "Gallic acid (GA) is a natural phenolic compound with therapeutic effects that are often challenged by its rapid metabolism and clearance." | 1.56 | Preparation, characterization and therapeutic properties of gum arabic-stabilized gallic acid nanoparticles. ( Azarian, MMS; Hassani, A; Hussain, SA; Ibrahim, WN, 2020) |
| "Gallic acid (GA) has been reported to have beneficial effects on cancer, vascular calcification, and diabetes-induced myocardial dysfunction." | 1.46 | Gallic Acid Reduces Blood Pressure and Attenuates Oxidative Stress and Cardiac Hypertrophy in Spontaneously Hypertensive Rats. ( Choi, SY; Jeong, MH; Jin, L; Kee, HJ; Kim, GR; Lin, MQ; Liu, B; Piao, ZH; Ryu, Y; Seok, YM; Sun, S, 2017) |
| " The protective effects of SA are mediated by reducing oxidative stress and retaining the bioavailability of NO in the cardiovascular system." | 1.38 | Syringic acid ameliorates (L)-NAME-induced hypertension by reducing oxidative stress. ( Kumar, S; Prahalathan, P; Raja, B, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Hassani, A | 1 |
| Azarian, MMS | 1 |
| Ibrahim, WN | 1 |
| Hussain, SA | 1 |
| Schlickmann, F | 1 |
| de Souza, P | 1 |
| Boeing, T | 1 |
| Mariano, LNB | 1 |
| Steimbach, VMB | 1 |
| Krueger, CMA | 1 |
| da Silva, LM | 1 |
| de Andrade, SF | 1 |
| Cechinel-Filho, V | 1 |
| Jin, L | 3 |
| Piao, ZH | 3 |
| Sun, S | 3 |
| Liu, B | 2 |
| Kim, GR | 3 |
| Seok, YM | 1 |
| Lin, MQ | 2 |
| Ryu, Y | 3 |
| Choi, SY | 3 |
| Kee, HJ | 3 |
| Jeong, MH | 3 |
| Haneef, J | 1 |
| Chadha, R | 1 |
| Liu, CP | 1 |
| Mihailovic-Stanojevic, N | 1 |
| Belščak-Cvitanović, A | 1 |
| Grujić-Milanović, J | 1 |
| Ivanov, M | 1 |
| Jovović, Dj | 1 |
| Bugarski, D | 1 |
| Miloradović, Z | 1 |
| Cho, JY | 1 |
| Kumar, S | 1 |
| Prahalathan, P | 1 |
| Raja, B | 1 |
| Buemi, M | 1 |
| Marino, D | 1 |
| Floccari, F | 1 |
| Ruello, A | 1 |
| Nostro, L | 1 |
| Aloisi, C | 1 |
| Marino, MT | 1 |
| Di Pasquale, G | 1 |
| Corica, F | 1 |
| Frisina, N | 1 |
| Shirakawa, H | 1 |
| Koseki, T | 1 |
| Ohinata, K | 1 |
| Hashizume, K | 1 |
| Komai, M | 1 |
| Tepel, M | 1 |
| Ruess, C | 1 |
| Mehring, N | 1 |
| Neusser, M | 1 |
| Zidek, W | 1 |
| Feng, JJ | 1 |
| Arendshorst, WJ | 2 |
| Salomonsson, M | 1 |
| Kuriyama, S | 1 |
| Nakamura, K | 1 |
| Horiguchi, M | 1 |
| Uchida, H | 1 |
| Sakai, O | 1 |
14 other studies available for gallic acid and Hypertension
| Article | Year |
|---|---|
Preparation, characterization and therapeutic properties of gum arabic-stabilized gallic acid nanoparticles.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Agents; Antioxidants; Apoptosis; Biphenyl C | 2020 |
Chemical composition and diuretic, natriuretic and kaliuretic effects of extracts of Mimosa bimucronata (DC.) Kuntze leaves and its majority constituent methyl gallate in rats.
Topics: Administration, Oral; Animals; Atropine; Cell Line; Disease Models, Animal; Diuretics; Gallic Acid; | 2017 |
Gallic Acid Reduces Blood Pressure and Attenuates Oxidative Stress and Cardiac Hypertrophy in Spontaneously Hypertensive Rats.
Topics: Angiotensin II; Animals; Blood Pressure; Blood Pressure Determination; Cardiomegaly; Gallic Acid; GA | 2017 |
Antioxidant-Based Eutectics of Irbesartan: Viable Multicomponent Forms for the Management of Hypertension.
Topics: Animals; Antihypertensive Agents; Antioxidants; Ascorbic Acid; Biphenyl Compounds; Calorimetry, Diff | 2018 |
Gallic acid attenuates calcium calmodulin-dependent kinase II-induced apoptosis in spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Atrial Natriuretic Factor; bcl-2-Associ | 2018 |
Antioxidant and antihypertensive activity of extract from Thymus serpyllum L. in experimental hypertension.
Topics: Animals; Antihypertensive Agents; Antioxidants; Caffeic Acids; Chromatography, High Pressure Liquid; | 2013 |
Gallic acid attenuates hypertension, cardiac remodeling, and fibrosis in mice with NG-nitro-L-arginine methyl ester-induced hypertension via regulation of histone deacetylase 1 or histone deacetylase 2.
Topics: Animals; Blood Pressure; Fibrosis; Gallic Acid; Heart Ventricles; Histone Deacetylase 1; Histone Dea | 2017 |
Syringic acid ameliorates (L)-NAME-induced hypertension by reducing oxidative stress.
Topics: Animals; Antioxidants; Biomarkers; Blood Pressure; Disease Models, Animal; Dose-Response Relationshi | 2012 |
Effect of interleukin 8 and ICAM-1 on calcium-dependent outflow of K+ in erythrocytes from subjects with essential hypertension.
Topics: Adult; Calcium; Calcium Channel Blockers; Erythrocyte Membrane; Female; Gallic Acid; Humans; Hyperte | 2004 |
Rice bran fractions improve blood pressure, lipid profile, and glucose metabolism in stroke-prone spontaneously hypertensive rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Blood Glucose; Blood Pressure; Catechin; Deoxyguanosine; Diet; | 2006 |
Effect of inhibition of sarcoplasmic Ca(2+)-ATPase on vasoconstriction and cytosolic Ca2+ in aortic smooth muscle from spontaneously hypertensive and normotensive rats.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium-Transporting ATPases; Cytosol; Gallic Acid; Hype | 1994 |
Calcium signaling mechanisms in renal vascular responses to vasopressin in genetic hypertension.
Topics: Animals; Arginine Vasopressin; Calcium; Dose-Response Relationship, Drug; Drug Combinations; Gallic | 1997 |
Norepinephrine-induced calcium signaling pathways in afferent arterioles of genetically hypertensive rats.
Topics: Adrenergic alpha-Agonists; Animals; Arterioles; Calcium; Calcium Channel Blockers; Calcium Channels; | 2001 |
Decreased insulin-sensitive Ca2+ transport in cultured vascular smooth muscle cells from spontaneously hypertensive rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amiloride; Animals; Biological Transport; Calcium; Ca | 1992 |